7月20日,由中关村精准医学基金会主办,远大医药(0512.HK)协办的“核新对话”——放射性核素诊疗一体化多学科专家研讨会在珠海成功召开。本次会议汇聚全国顶尖医院的核医学、肝胆外科、介入治疗等领域专家,共同探讨以远大医药的SIR-Spheres® 钇[90Y]微球注射液(易甘泰®)为代表的放射性核素诊疗一体化技术新进展新格局,以期共同探索多学科协作(MDT)创新路径,推动我国核医学精准治疗规范化...
Source Link7月20日,由中关村精准医学基金会主办,远大医药(0512.HK)协办的“核新对话”——放射性核素诊疗一体化多学科专家研讨会在珠海成功召开。本次会议汇聚全国顶尖医院的核医学、肝胆外科、介入治疗等领域专家,共同探讨以远大医药的SIR-Spheres® 钇[90Y]微球注射液(易甘泰®)为代表的放射性核素诊疗一体化技术新进展新格局,以期共同探索多学科协作(MDT)创新路径,推动我国核医学精准治疗规范化...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.